BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 2)

Ivermectin warning: Increased Poison Control calls in Mississippi

By

By NewsDesk  @infectiousdiseasenews The Mississippi state health authorities issued a health alert Friday due to increased Poison Control calls due to ivermectin ingestion and potential toxicity. The...

Cholesterol medication, Fenofibrate, could reduce SARS-CoV-2 infection by up to 70 per cent: UK study

By

A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 per cent, reveals a study in the laboratory by...

Antibiotics: DALVANCE receives FDA approval

By

AbbVie announced Friday that the U.S. Food and Drug Administration (FDA) approved DALVANCE® (dalbavancin) for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in pediatric...

Sleeping sickness: Fexinidazole receives FDA approval for treatment

By

By NewsDesk  @infectiousdiseasenews The US Food and Drug Administration (FDA) has approved fexinidazole as the first all-oral treatment for both stages of sleeping sickness (human African trypanosomiasis). Fexinidazole was...

Staph

New antibiotic for treating MRSA, KIMYRSA, now commercially available

By

By NewsDesk  @infectiousdiseasenews Morristown, NJ pharmaceutical company, Melinta Therapeutics announced this week that their lipoglycopeptide antibiotic, KIMYRSA™ (oritavancin), is now commercially...

Antibiotic, Solosec, receives FDA approval as treatment of trichomoniasis

By

By NewsDesk  @infectiousdiseasenews Today, the U.S. Food and Drug Administration (FDA) approved Lupin Pharmaceuticals supplemental New Drug Application (sNDA) to expand the use of SOLOSEC® (secnidazole)...

Anti-infective therapy for infections caused by drug-resistant gram-negative pathogens now in Phase I study

By

By NewsDesk  @infectiousdiseasenews Biopharmaceutical company, Qpex Biopharma, announced this week the initiation of a Phase 1 study of QPX9003, a next generation intravenous (IV)-administered synthetic...

Lyme disease prevention: Tarsus Pharmaceuticals initiates clinical trial for oral, non-vaccine TP-05

By

By NewsDesk  @infectiousdiseasenews TP-05 is designed to kill infected ticks attached to the human body before they can transmit the Borrelia bacteria that causes Lyme disease Late clinical-stage biopharmaceutical...

Monoclonal antibody prevents HIV infection in monkeys, study finds

By

An experimental, lab-made antibody can completely prevent nonhuman primates from being infected with the monkey form of HIV, new research published in Nature Communications shows. The results will inform...

Smallpox drug, Tembexa, receives FDA approval

By

By NewsDesk  @infectiousdiseasenews The U.S. Food and Drug Administration Friday approved Tembexa (brincidofovir) to treat smallpox. Although the World Health Organization declared smallpox, a contagious...